ELEDON PHARMACEUTICALS INC. - COMMON STOCK

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 12 2023 18:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

29 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

09 11 2023 16:01:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

08 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

02 11 2023 09:05:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer

23 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting

13 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors

02 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human

25 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference

20 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

11 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates

06 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation

16 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results

10 8 2023 07:00:01 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference

02 6 2023 08:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports First Quarter 2023 Operating and Financial Results

11 5 2023 16:01:01 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

04 5 2023 16:05:03 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials

01 5 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology

31 3 2023 06:00:00 提供 Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results

30 3 2023 16:01:00 提供 Nasdaq GlobeNewswire